2352: Investments In AIoT And Medical Services Will Boost Future Profitability

Key Takeaways

• Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.
  
• Geographic and market diversification efforts, including facilities in Vietnam and India, enhance resilience against geopolitical risks and boost sales.
  
• Weaker business segments, inventory risks, increased financial debt, geopolitical uncertainties, and delayed IT sector recovery may hinder Qisda's revenue growth and profitability.

Catalysts

Manufactures, sells, and services monitors, opto-mechatronics products, and optoelectronics film in Taiwan, the Americas, Mainland China, Japan, and internationally.

• Qisda’s strategic focus on AIoT and AI computing power, including investments in new technologies like immersion cooling solutions and smart automation, suggests potential for increased future revenue streams and improved gross margins.
  
• The planned hospital IPO and expansion of medical services, including the integration of Ding Ding Drug Store and increased focus on high-margin medical devices, could drive revenue and profitability in the medical business segment.
  
• Geographic and market diversification, including new facilities in Vietnam and India and a focus on emerging markets, could lead to enhanced resilience against geopolitical risks and boost sales, impacting overall revenue positively.
  
• Investment in new market segments, such as renewable energy and automation, as well as digital transformation services, might result in higher revenue and operating income as these markets mature.
  
• The company's ongoing cost management strategies, including inventory control and operational efficiencies, coupled with a recovery in the demand for IT and NCG products, could improve net margins and earnings growth in the upcoming quarters.

Qisda Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Qisda's revenue will grow by 4.8% annually over the next 3 years.
• Analysts assume that profit margins will increase from 0.5% today to 3.1% in 3 years time.
• Analysts expect earnings to reach NT$7.6 billion (and earnings per share of NT$4.79) by about June 2029, up from NT$977.2 million today.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 8.4x on those 2029 earnings, down from 48.4x today. This future PE is lower than the current PE for the TW Tech industry at 22.6x.
• Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.19%, as per the Simply Wall St company report.

Risks

• The company reported a 4% decline in year-to-date revenue compared to the previous year, highlighting weaker performance in certain business groups like NCG and BSG, which could negatively impact future revenue and earnings growth.
  
• An increase in inventory by NTD 2.6 billion, likely in preparation for the fourth quarter, carries risks of overstock if the anticipated demand does not materialize, potentially affecting net margins.
  
• Financial debt rose by NTD 12.9 billion due to capital allocation strategies, which could strain future cash flows and affect net earnings if not managed effectively.
  
• The uncertain outcome of the U.S. presidential election, particularly if Trump is elected, poses risks of geopolitical shifts affecting trade policies, tariffs, and supply chain dynamics, potentially impacting overall profitability.
  
• The delayed recovery in the IT sector, due to post-pandemic inventory digestion and lower demand, may slow overall revenue recovery and impact margins longer than expected.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of NT$32.6 for Qisda based on their expectations of its future earnings growth, profit margins and other risk factors.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be NT$241.2 billion, earnings will come to NT$7.6 billion, and it would be trading on a PE ratio of 8.4x, assuming you use a discount rate of 7.2%.
• Given the current share price of NT$29.95, the analyst price target of NT$32.6 is 8.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.